Cargando…
Osteosarcoma transcriptome data exploration reveals STC2 as a novel risk indicator in disease progression
BACKGROUND: Osteosarcoma has been the most common primary bone malignant tumor in children and adolescents. Despite the considerable improvement in the understanding of genetic events attributing to the rapid development of molecular pathology, the current information is still lacking, partly due to...
Autores principales: | Wang, Ziyue, Zeng, Zixin, Gao, Feng, Gui, Ziwei, Du, Juan, Shen, Ningning, Shang, Yangwei, Yang, Zhiqing, Shang, Lifang, Wei, Rong, Ma, Wenxia, Wang, Chen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9942349/ https://www.ncbi.nlm.nih.gov/pubmed/36803385 http://dx.doi.org/10.1186/s12920-023-01456-4 |
Ejemplares similares
-
Molecular profiling of gene fusions in soft tissue sarcomas by Ion AmpliSeq(TM): a study of 35 cases
por: Wei, Rong, et al.
Publicado: (2022) -
IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
por: Wei, Rong, et al.
Publicado: (2021) -
Immune regulation and prognosis indicating ability of a newly constructed multi-genes containing signature in clear cell renal cell carcinoma
por: Gui, Ziwei, et al.
Publicado: (2023) -
Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development
por: Wei, Rong, et al.
Publicado: (2020) -
Research progress of STC2 in breast cancer
por: Niu, Xuezhi, et al.
Publicado: (2021)